课题基金 / 基金详情

Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis

Research for molecular mechanisms of lymphangiogenesis and lymph node metastasis
淋巴管生成及淋巴结转移的分子机制研究
批准号:
16390378
负责人:
KUBO Hajime
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

KUBO Hajime的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.The expression of lymphatic marker, podoplanin by cancer were associated with the frequency of lymph node metastasis.We established novel anti-human podoplanin antibodies, and found the expression by several cancer cells using tissue microarrays. We also found that podoplanin was the specific marker for mesothelioma.2.Homeobox gene, prox1 as a novel tumor suppressor gene.We found that there was a significant correlation between prox1 expression and the differentiation scores of the tumors. Subsequently, we also showed that low expression of prox1 in tumors was closely associated with a poor prognosis. The specific knockdown of prox1 by RNA interference strongly accelerated in vitro cell growth, while the over-expression of prox1 greatly suppressed the growth.3.Two populations of Thy1-positive mesenchymal cells regulate the in vitro maturation of hepatic progenitor cellsWe determined that the mucin-type transmembrane glycoprotein gp38 could distinguish the cuboidal cells from the spin … More dle cells by immunocytochemistry. In vitro maturation of hepatic progenitor cells promoted by gp38-positive cells may be opposed by an inhibitory effect of gp38-negative cells, which likely maintain the immature, proliferative state of CD49f-positive cells.4.Differentiation of lymphatic endothelial cells from Embryonic Stem cells on OP9 stromal cellsVEGFR-2^+ cells derived from ES cells differentiated into LECs at day3 on OP9 stromal cells defined by the expression of prox1, VEGFR-3 and another lymphatic marker podoplanin. VEGFR-2^+ cells gave rise to LYVE-1^+ embryonic ECs, which were negative for prox1 on day1 but turned to prox1^+ LECs by day3. VEGFR3-Fc or Tie2-Fc, sequestering VEGF-C or angiopoietin 1 (Ang1), suppressed colony formation of LECs on OP9 cells. However, addition of VEGF-C and Ang1 in combination with VEGF to the culture of VEGFR-2^+ cells on collagen-coated dishes failed to induce LECs. LEC inducing activity of OP9 cells was fully reproduced on PFA-fixed OP9 cells with the conditioned medium. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
All-trans retinoic acid modulates proliferation of lung fibroblasts via IL-6/IL-6R system.
全反式维A酸通过IL-6/IL-6R系统调节肺成纤维细胞的增殖。
DOI: --
发表时间: 2006
期刊: Am J Physiol Lung Cell Mol Physiol. 290
影响因子: --
作者: [Tabata C, Kubo H, Tabata R, Wada M, Sakuma K, Ichikawa M, Fujita S, Mio T, Mishima M]
通讯作者: Mishima M
DOI: 10.1111/j.1349-7006.2004.tb03211.x
发表时间: 2004-04
期刊: Cancer Science
影响因子: 5.7
作者: [K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;]
通讯作者: K. Shimizu;H. Kubo;K. Yamaguchi;K. Kawashima;Y. Ueda;Koichi Matsuo;M. Awane;Y. Shimahara;
Molecular mechanisms of lymphangiogenesis in diseases.
疾病中淋巴管生成的分子机制。
DOI: --
发表时间: 2004
期刊: Microcirculation annual. 20
影响因子: --
作者: [Kubo H., Kono T]
通讯作者: Kono T
DOI: 10.1097/01.pas.0000172192.25295.45
发表时间: 2005-10-01
期刊: AMERICAN JOURNAL OF SURGICAL PATHOLOGY
影响因子: 5.6
作者: [Kumasaka, T, Seyama, K, Suda, K]
通讯作者: Suda, K
Targeting therapy against cancer stem cells
  • 批准号:
    20390341
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.31万
  • 财政年份:
    2008
  • 负责人:
    KUBO Hajime
  • 依托单位:
Anovel mechanism of tumor progression by the candidate tumor suppressor Proxl : RNA mutation in cancer
  • 批准号:
    18390345
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.28万
  • 财政年份:
    2006
  • 负责人:
    KUBO Hajime
  • 依托单位:
Lymphangiogenesis in cancer
  • 批准号:
    17014047
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 资助金额:
    $29.06万
  • 财政年份:
    2005
  • 负责人:
    KUBO Hajime
  • 依托单位:
海外基金